Category: Hematology & Oncology
Hematology & Oncology market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Cancer Testing-Screening
The 2025-2030 World Outlook for Cancer Testing-Screening This study covers the world outlook for cancer testing-screening across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Oncology Companion Diagnostics
The 2025-2030 World Outlook for Oncology Companion Diagnostics This study covers the world outlook for oncology companion diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Noninvasive Cancer Diagnostics
The 2025-2030 World Outlook for Noninvasive Cancer Diagnostics This study covers the world outlook for noninvasive cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Veterinary Oncology
The 2025-2030 World Outlook for Veterinary Oncology This study covers the world outlook for veterinary oncology across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Pap Smear Tests for Cervical Cancer Diagnostic Testing
The 2025-2030 World Outlook for Pap Smear Tests for Cervical Cancer Diagnostic Testing This study covers the world outlook for pap smear tests for cervical cancer diagnostic testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indust ... Read More
-
The 2025-2030 World Outlook for Cancer Diagnostics
The 2025-2030 World Outlook for Cancer Diagnostics This study covers the world outlook for cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for Hemato Oncology Testing
The 2025-2030 World Outlook for Hemato Oncology Testing This study covers the world outlook for hemato oncology testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Oncology Based Molecular Diagnostics
The 2025-2030 World Outlook for Oncology Based Molecular Diagnostics This study covers the world outlook for oncology based molecular diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More
-
The 2025-2030 World Outlook for Lung Cancer Diagnostics
The 2025-2030 World Outlook for Lung Cancer Diagnostics This study covers the world outlook for lung cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Immuno-Oncology Immune Checkpoint Inhibitors
The 2025-2030 World Outlook for Immuno-Oncology Immune Checkpoint Inhibitors This study covers the world outlook for immuno-oncology immune checkpoint inhibitors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.) ... Read More
-
The 2025-2030 World Outlook for Rare Hematology Plasma-Derived Factors
The 2025-2030 World Outlook for Rare Hematology Plasma-Derived Factors This study covers the world outlook for rare hematology plasma-derived factors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Diagnostic Products
The 2025-2030 World Outlook for Breast Cancer Diagnostic Products This study covers the world outlook for breast cancer diagnostic products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Diagnostics
The 2025-2030 World Outlook for Breast Cancer Diagnostics This study covers the world outlook for breast cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Hematology Instruments and Reagents
The 2025-2030 World Outlook for Hematology Instruments and Reagents This study covers the world outlook for hematology instruments and reagents across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Prostate Cancer Diagnostics
The 2025-2030 World Outlook for Prostate Cancer Diagnostics This study covers the world outlook for prostate cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Gynecologic Oncology
The 2025-2030 World Outlook for Gynecologic Oncology This study covers the world outlook for gynecologic oncology across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Head and Neck Cancer Diagnostics
The 2025-2030 World Outlook for Head and Neck Cancer Diagnostics This study covers the world outlook for head and neck cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
-
The 2025-2030 World Outlook for Hematology and Coagulation Instruments
The 2025-2030 World Outlook for Hematology and Coagulation Instruments This study covers the world outlook for hematology and coagulation instruments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More
-
The 2025-2030 World Outlook for Lymphedema Diagnostics
The 2025-2030 World Outlook for Lymphedema Diagnostics This study covers the world outlook for lymphedema diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Womens Health Diagnostics
The 2025-2030 World Outlook for Womens Health Diagnostics This study covers the world outlook for womens health diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Gastric Cancer Diagnostics, Screenings, and Treatments
The 2025-2030 World Outlook for Gastric Cancer Diagnostics, Screenings, and Treatments This study covers the world outlook for gastric cancer diagnostics, screenings, and treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indust ... Read More
-
The 2023-2028 World Outlook for Rare Hematology Plasma-Derived Factors
The 2023-2028 World Outlook for Rare Hematology Plasma-Derived Factors This study covers the world outlook for rare hematology plasma-derived factors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More
-
The 2023-2028 World Outlook for Hematology Analyzers
The 2023-2028 World Outlook for Hematology Analyzers This study covers the world outlook for hematology analyzers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2023-2028 World Outlook for Oncology Companion Diagnostics
The 2023-2028 World Outlook for Oncology Companion Diagnostics This study covers the world outlook for oncology companion diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2023-2028 World Outlook for Next Generation Cancer Diagnostics
The 2023-2028 World Outlook for Next Generation Cancer Diagnostics This study covers the world outlook for next generation cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More
Research Assistance
